3.3 Lung Cancer - Comeau

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/102

encourage image

There's no tags or description

Looks like no tags are added yet.

Last updated 6:43 PM on 4/12/26
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai

No analytics yet

Send a link to your students to track their progress

103 Terms

1
New cards
<p>what causes 90% of all lung cancer cases?</p>

what causes 90% of all lung cancer cases?

cigs

2
New cards

what are some environmental exposures that can cause lung cancer?

asbestos

2nd hand smoke

3
New cards

what is the number 1 method to prevent lung cancer?

DONT SMOKE

<p>DONT SMOKE</p>
4
New cards

most common stage of lung cancer at diagnosis

IV distant/ metastatic

5
New cards

overall survival of stage IV (distant/ metastatic lung cancer)

9.7% of ppl

6
New cards

what is the gold standard screening procedure for lung cancer?

low dose helical CT

7
New cards

what are the requirements to be screened for LC?

must be 50-80 yrs old

must have >/= 20 pack year

must have smoked or is currently smoking

(MUST HAVE ALL)

8
New cards

if a pt meets all requirements for LC screening, how often should they be screened?

every year big dog

9
New cards

how to determine pack year?

number of packs a day x number of years smoked

10
New cards

what are the two types of LC?

small cell

non-small cell

11
New cards

what are the types NSCLC?

adenocarcinoma

squamous cell carcinoma

large cell carcinoma

12
New cards

describe the metastasis pathway for LC

lungs —> lymph nodes —> brain —> bone —> liver —> adrenal glands

13
New cards

non metastatic LC can be treated with…

local methods (radiation and surgery)

14
New cards

metastatic LC can be treated with…

systemic tx (can add local methods too)

15
New cards

60-70% of all LC’s are extensive small cell LC,

  1. what is the cure rate

  2. what is the median survival after diagnosis

  3. what percent of pts make it to 5 years post diagnosis?

  1. 0%

  2. 8-13 months

  3. 1-2%

16
New cards

limited small cell LC treatment goal

cure

17
New cards

extensive SCLC treatment goal

palliative

18
New cards

limited stage small cell LC:

what is the treatment sequence?

concurrent chemoradiation then immunotherapy if stable or better

19
New cards

What is the purpose of adding chemotherapy to radiation in limited-stage disease LC?

increases survival odds

20
New cards

small cell LC:

What is the preferred chemotherapy regimen with CRT?

cisplatin + etoposide

21
New cards

what does platinum doublet mean??

platinum + other drug

22
New cards

SCLC:

if cisplatin is CI or not tolerated, what can we give instead?

carboplatin

23
New cards

What supportive care is important with platinum therapy?

fluids

24
New cards

small cell LC:

what class of immunotherapy agents are used?

immune checkpoint inhibitors

25
New cards

what are the two classes of immune checkpoint inhibitors

PDL1 and PD1 inhibitors

26
New cards

Cisplatin and Carboplatin ADE/Tox

CINV

renal and electrolyte abnormalities

ototoxicity

27
New cards

which platinum causes more myelosuppression?

carboplatin

28
New cards

What is the risk of giving G-CSF with concurrent chemoradiation (CRT)?

increased risk of death (yikes)

29
New cards

how do immunotherapy agents work for LC?

they inhibit T cell deactivation and increase T cell activation so the T cells can attack the cancer cells

30
New cards

similarities between the immunotherapy options for LC

same ADEs

same MOA

all given IV

31
New cards

what are the PD1 inhibitors?

Nivolumab

Pembrolizumab

Cemiplimab

32
New cards

what are the PDL1 inhibitors?

Atezolizumab

Durvalumab

33
New cards

Why must patients be evaluated for autoimmune disease before immunotherapy?

Immunotherapy can worsen autoimmune diseases

34
New cards

what is the drug and dose to treat moderate to severe immunotherapy ADE?

prednisone 1 mg /kg / day

35
New cards

What may need to happen to PD-1/PD-L1 therapy in moderate–severe irAEs?

Hold or discontinue therapy

36
New cards

How long should steroids be tapered in severe irAEs?

long taper

37
New cards

When should PJP/pneumonia prophylaxis be started in irAE treatment?

if pt is on steroid (prednisone) for 4 weeks or more

38
New cards

pts with severe IRAE on steroids for 4 weeks or more should be started on ______ for PJP prophylaxis

bactrim

39
New cards

What is the most common endocrine irAE?

hypothyroidism

40
New cards

How often should TSH and fT4 be monitored during immunotherapy?

every 4-6 weeks

41
New cards

What defines overt hypothyroidism?

High TSH + low fT4

42
New cards

if a pt has overt hypothyroidism (High TSH + low fT4) they should be treated with…

levothyroxine

43
New cards

How is irAE dermatitis managed?

topical agents

if itchy give po antihistamine (diphenhydramine)

44
New cards

What non-pharma care is used for irAE colitis?

BRAT diet and hydration

45
New cards

What medication can be used for short-term symptom control in colitis?

loperamide

46
New cards

What is the most common cause of death from irAEs?

Pneumonitis

47
New cards

What must be ruled out in suspected pneumonitis from immunotherapy?

infections (CAP)

48
New cards

What antibiotics cover atypicals in pneumonitis?

Levofloxacin, azithromycin, doxycycline

49
New cards

What is the first-line treatment for extensive-stage small cell LC?

platinum + etoposide + immunotherapy then do immunotherapy till progression

50
New cards

which immunotherapy medications are used for extensive small cell LC?

atezolizumab or durvalumab

51
New cards

brain radiation is obviously toxic af, what drug should be added to help prevent neurocognitive impairment?

memantine

52
New cards

non-small cell LC treatment goals:

  1. respectable /local

  1. inoperable

  2. metastatic

  1. cure

  2. control dx

  3. palliative

53
New cards

what is the driver mutation for non small cell LC?

EGFR sensitizing

54
New cards

what is the most common driver mutation target in non small cell LC?

EGFR

55
New cards

pts with a ____ % of tumor cells with PDL1 respond better to immunotherapy

a. lower

b. higher

b

56
New cards

non small cell LC:

treatment for nonresectable, locally advanced stage IIIB-C

platinum doublet with concurrent radiation

57
New cards

Why is chemotherapy added to radiation for non small cell LC?

increases efficacy of radiation therapy

58
New cards

adenocarcinoma treatment options

platinum with either pemetrexed, etoposide, OR paclitaxel

59
New cards

What regimens are used for adenocarcinoma (only)?

platinum + pemetrexed

60
New cards

squamous non small cell LC treatment option

platinum with either etoposide or paclitaxel

61
New cards

which chemo agent is CI in squamous non small cell LC?

pemetrexed

62
New cards

What is the initial treatment for unresectable Stage IIIB–C NSCLC?

Concurrent chemoradiation (CRT)

63
New cards

What is given after CRT if disease is stable or improved?

immunotherapy (durvalumab)

64
New cards

What is used after CRT in patients with EGFR-mutated NSCLC?

Osimertinib

65
New cards

What is the first step in treating Stage IV metastatic NSCLC?

check for targetable mutations

66
New cards

Patient has adenocarcinoma with a targetable mutation—what is first-line treatment?

targeted therapy for that mutation

67
New cards

if a pt has stage IV metastatic NSCLC (adenocarcinoma or squamous cell carcinoma, WITH NO mutations, what determines treatment?

PDL1 expression

68
New cards

How is Stage IV NSCLC treated if PD-L1 ≥ 50%?

single agent immunotherapy (pembrolizumab) or pembrolizumab + platinum doublet

69
New cards

How is Stage IV NSCLC treated if PD-L1 < 50%?

pembrolizumab + platinum doublet

70
New cards

What are the two most common EGFR mutations in NSCLC?

  • Exon 19 deletion

  • L858R exon 21 mutation

71
New cards

What is the preferred first-line treatment for EGFR-mutated NSCLC?

Osimertinib

72
New cards

What combination can be used with osimertinib in EGFR-mutated NSCLC?

Osimertinib + platinum + pemetrexed

73
New cards

What is another targeted combination for EGFR-mutated NSCLC?

Lazertinib + amivantamab

74
New cards

What is the are the common adverse effect of osimertinib?

rash and diarrhea

75
New cards

describe the rash that osimertinib causes in over half of the pts on it

dry skin with acne like rash

76
New cards

non pharmacological measures to treat osimertinib induced rash

avoid sun, use sunscreen, and moisturize

77
New cards

how is a mild EGFR inhibitor (osimertinib) rash managed?

topical agents (hydrocortisone and clindamycin)

78
New cards

how is moderate EGFR inhibitor (osimertinib) induced rash treated?

try different topical steroids AND doxycycline or minocycline

79
New cards

how to treat osimertinib induced diarrhea?

give loperamide

80
New cards

what is a common ADE seen with EGFR-targeted therapies (lazertinib + amivantamab)?

Rash/skin toxicities (~40%)

81
New cards

How are EGFR-related skin toxicities managed prophylactically?

doxycycline or minocycline

clindamycin topical

moisturizer

82
New cards

What receptors does amivantamab target?

EGFR

MET

83
New cards

What are common ADE of amivantamab?

Peripheral edema

Infusion-related reactions

84
New cards

What is a major systemic risk with the lazertinib + amivantamab regimen?

VTE

85
New cards

how to prevent VTE due to lazertinib + amivantamab?

prophylactic anticoagulation

86
New cards

When is single-agent immunotherapy indicated up-front in Stage IV NSCLC?

PD-L1 ≥ 50% on tumor cells

87
New cards

What medication is most used for single-agent immunotherapy for nsclc?

pembrolizumab

88
New cards

Can chemotherapy + immunotherapy be used regardless of PD-L1 expression?

yes (any pt)

89
New cards

When is chemo + immunotherapy strongly recommended based on PD-L1?

PDL1 < 50%

90
New cards

What is the chemo + immunotherapy regimen for adenocarcinoma?

carboplatin + pemetrexed + pembrolizumab

91
New cards

What is the chemo + immunotherapy regimen for squamous cell carcinoma?

carboplatin + paclitaxel or nab-paclitaxel + pembrolizumab

92
New cards

What supportive care is used to prevent myelosuppression and mucositis due to pemetrexed ( in a pt with non-squamous adenocarcinoma)?

folic acid and vitamin B12

93
New cards

What is used to prevent dermatologic toxicities with pemetrexed? (in a pt with non-squamous adenocarcinoma)

dexamethasone

94
New cards

Which irAE is more common with platinum/pemetrexed/pembrolizumab regimens?

Nephritis

95
New cards

most common ADE of pembrolizumab

AKI (nephritis)

96
New cards

What is a key adverse effect of paclitaxel?

Infusion-related reactions (due to inactive ingredient)

97
New cards

What premedications are required for paclitaxel to prevent infusion reactions?

H1 inhibitor + H2 inhibitor + dexamethasone

98
New cards

Are premedications required for nab-paclitaxel to prevent infusion related reactions?

nah fam

99
New cards

What causes SVC syndrome?

Compression of the superior vena cava → obstruction of blood flow

100
New cards

How is SVC syndrome treated in small cell lung cancer (SCLC)?

Chemotherapy ± radiation